间歇性禁食单用或联合益生菌补充对比热量限制饮食对多囊卵巢综合征患者代谢与激素谱的影响:随机临床试验研究方案
该研究为8周随机临床试验方案,拟将多囊卵巢综合征(PCOS)女性按1:1:1随机分为三组:14:10早期限时进食联合益生菌组(n=30)、14:10早期限时进食联合安慰剂组(n=30)及热量限制饮食联合安慰剂对照组(n=30)。主要结局为体重和胰岛素抵抗变化,次要结局涵盖血糖控制、血脂、代谢参数、激素、抗氧化与炎症指标及心理健康等,所有结局均在干预前后评估。
要点
- PCOS女性随机接受14:10早期限时进食联合益生菌、14:10早期限时进食联合安慰剂或热量限制饮食,疗程8周。
- 主要结局为体重和胰岛素抵抗变化,次要结局包括血糖、血脂、激素、炎症、氧化应激及心理健康等多维度指标。
- 研究假设限时进食单用或联合益生菌较标准每日三餐热量限制饮食可改善体重及代谢、激素、炎症和抗氧化标志物。
核心结论
- 研究假设在超重和肥胖PCOS受试者中,10小时限时进食单用或联合益生菌补充,较标准每日三餐热量限制饮食的对照受试者,可导致体重减轻并改善代谢、激素、炎症和抗氧化标志物。
研究设计与样本
- 随机临床试验研究方案,为期8周,受试者按1:1:1随机分配至三组。
- 第1组:14:10早期限时进食饮食联合益生菌补充(n=30)。
- 第2组:14:10早期限时进食饮食联合安慰剂补充(n=30)。
- 第3组:热量限制饮食(能量限制为所需热量的25%)联合安慰剂补充作为对照组(n=30)。
- 所有结局在干预前和干预后评估。
主要发现
- 主要结局为体重和胰岛素抵抗的变化。
- 次要结局包括血糖控制、血脂谱、代谢参数、性激素结合球蛋白、脱氢表雄酮、抗苗勒管激素、游离雄激素指数、多毛症、痤疮、抗氧化与氧化状态、炎症、人体测量指标、心理健康、睡眠质量、食欲、进食行为、食物渴求及血压。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in females characterized by ovulatory dysfunction, hyperandrogenism, and other metabolic disorders. Both intermittent fasting and specific probiotics have been suggested to help improve patients with PCOS through changes in gut microbial composition, circadian clock, and metabolic regulation. Therefore, the present study aims to investigate the effects of intermittent fasting alone or in combination with probiotic supplementation compared to the calorie-restricted (CR) diet on anthropometric measures, metabolic status, inflammation, and oxidative stress in women with PCOS. METHODS: We will carry out a randomized clinical trial for 8 weeks. Participants will be randomly assigned (1:1:1) to one of the three groups: (1) a 14:10 early time-restricted feeding (TRF) diet with probiotic supplementation (n = 30); (2) a 14:10 early TRF diet with placebo supplementation (n = 30); (3) a CR diet (energy-restricted 25% of required calories) with placebo supplementation as a control group (n = 30). The primary outcomes will be changes in body weight and insulin resistance. However, glycemic control, lipid profile, metabolic parameters, sex hormone-binding globulin, dehydroepiandrosterone, anti-Mullerian hormone, free androgen index, hirsutism, acne, antioxidant and oxidant status, inflammation, anthropometric measures, mental health, sleep quality, appetite, eating behavior, food craving, and blood pressure are secondary outcomes. All outcomes of this study will be evaluated in pre- and post-intervention. DISCUSSION: We hypothesized that 10-h TRE administered alone or in combination with probiotic supplementation to overweight and obese PCOS subjects would lead to weight loss and improved metabolic, hormonal, inflammatory, and antioxidant markers compared to control subjects following a standard 3-meal-per-day CR diet. ETHICAL ASPECTS: The current trial received approval from the Medical Ethics Committee of Tehran University of Medical Sciences, Tehran, Iran (IR.TUMS.MEDICNE.REC.1401.425). TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT20121110011421N5. Registered on 3 October 2022.
引用
- Talebi S, Shab-Bidar S, Mohammadi H, et al. The effects of intermittent fasting diet alone or in combination with probiotic supplementation in comparison with calorie-restricted diet on metabolic and hormonal profile in patients with polycystic ovary syndrome: study protocol for a randomized clinical trial. Trials. 2023. PMID: 37880791. doi:10.1186/s13063-023-07691-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。